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DISC1 inﬂuences susceptibility to psychiatric disease and related phenotypes. Intact functions of DISC1 and
its binding partners, NDEL1 and NDE1, are critical to neurodevelopmental processes aberrant in schizo-
phrenia (SZ). Despite evidence of an NDEL1–DISC1 protein interaction, there have been no investigations
of the NDEL1 gene or the relationship between NDEL1 and DISC1 in SZ. We genotyped six NDEL1 single-
nucleotide polymorphisms (SNPs) in 275 Caucasian SZ patients and 200 controls and tested for association
and interaction between the functional SNP Ser704Cys in DISC1 and NDEL1. We also evaluated the relation-
ship between NDE1 and DISC1 genotype and SZ. Finally, in a series of in vitro assays, we determined the
binding proﬁles of NDEL1 and NDE1, in relation to DISC1 Ser704Cys. We observed a single haplotype
block within NDEL1; the majority of variation was captured by NDEL1 rs1391768. We observed a signiﬁcant
interaction between rs1391768 and DISC1 Ser704Cys, with the effect of NDEL1 on SZ evident only against the
background of DISC1 Ser704 homozygosity. Secondary analyses revealed no direct relationship between
NDE1 genotype and SZ; however, there was an opposite pattern of risk for NDE1 genotype when conditioned
on DISC1 Ser704Cys, with NDE1 rs3784859 imparting a signiﬁcant effect but only in the context of a Cys-car-
rying background. In addition, we report opposing binding patterns of NDEL1 and NDE1 to Ser704 versus
Cys704, at the same DISC1 binding domain. These data suggest that NDEL1 signiﬁcantly inﬂuences risk
for SZ via an interaction with DISC1. We propose a model where NDEL1 and NDE1 compete for binding
with DISC1.
INTRODUCTION
Emerging evidence suggests that the gene disrupted in
schizophrenia-1 (DISC1) confers an increased risk for
a range of psychiatric illnesses (1,2), including major
depression (3), bipolar disorder, schizoaffective disorder and
schizophrenia (SZ) (4). Moreover, several recent studies
have observed a link between DISC1 genotype and elements
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other manifestations of illness such as reduced cerebral grey
matter (5,8) and severity of positive psychotic symptoms
(10). The mechanism by which DISC1 confers these effects
on brain structure and function remains to be elucidated;
however, the complexity of these phenotypes indicates that
its action may be mediated by multiple loci within DISC1
and/or through interactions with critical binding partners.
The DISC1 protein is multifunctional and has at least 10
binding partners, many of which are involved in cell division
and intracellular transport (2,7,11). Of particular interest are
nuclear distribution element like (NDEL1) and its homolog,
NDE1, centrosomal proteins involved in mitosis, neuronal
migration and microtubule organization during brain develop-
ment (12–14). Both NDEL1 and NDE1 were identiﬁed via
their interactions with lissencephaly 1 (LIS1), a gene in
which mutations cause human lissencephaly (15–19). These
LIS1 mutations inhibit binding to NDEL1 and cause an abnor-
mal pattern of cortical development resulting in the appear-
ance of a ‘smoothed brain’ (16). NDEL1 has been
demonstrated to act as a modulator of dynein function and
as a critical component for centrosome–nucleus coupling
during neuronal migration (12). A critical role of NDE1 in
neurodevelopment was demonstrated in an NDE1-deﬁcient
mouse model (NDE1 knock out), in which the mice presented
with microcephaly, reduced progenitor cell division and
alterations in mitotic spindle formation and in chromosome
segregation (16). Although NDE1 and NDEL1 share some
common features, for example both interact with cytoplasmic
dynein, a microtubule-dependent motor complex (18), they are
distinct in their functions related to chromosomal alignment
and segregation (20).
There is preliminary evidence that NDEL1’s function in
neurodevelopment may be related to the pathophysiology of
SZ (21,22). Biological data suggest that if NDEL1 plays a
role in the etiology of SZ, it may do so via an interaction
with the DISC1 protein. Lipska et al. (23) demonstrated that
NDEL1 expression is decreased in the hippocampus (HC) of
patients with SZ. Further, they reported an association
between NDEL1 expression and three alleles inﬂuencing risk
for SZ within the DISC1 gene, with these alleles consistently
predicting reduced NDEL1 expression. Similarly, in a study
by Kamiya et al. (24), results from yeast two-hybrid assays
suggest that genetic variation at loci proximal to the
DISC1–NDEL1 interaction domain modulates the binding
afﬁnity of NDEL1 to DISC1. Functionally, an intact
NDEL1–DISC1 interaction has been shown to be critical to
multiple neurodevelopmental processes that are abnormal in
SZ including neural outgrowth (25). On the basis of this con-
vergent evidence, we hypothesized that the gene that codes for
NDEL1 (NDEL1 located on chromosome 17p13.1) may be
involved in the pathophysiology of SZ, perhaps via interaction
with DISC1.
Nuclear distribution gene E homolog 1 (NDE1), the
homolog of NDEL1, is located on chromosome 16p13.11.
There is early evidence that NDE1 may also play a role in sus-
ceptibility to SZ, and that its actions in this context may also
be directly linked to DISC1 function. In a recent linkage study,
Hennah et al. (26) identiﬁed a critical interaction between a
DISC1 risk haplotype (HEP3) and NDE1 and risk for SZ in
a Finnish sample. In an initial linkage analysis, the chromoso-
mal region containing NDE1 showed no evidence for linkage;
however, once conditioned on the presence of a previously
identiﬁed risk haplotype in DISC1, signiﬁcant linkage was
detected in this region but only in carriers of the risk haplo-
type. Follow-up analyses revealed a signiﬁcant association
with a haplotype within the NDE1 gene and SZ in these sub-
jects. A more recent study in a Japanese SZ population failed
to replicate these ﬁndings in NDE1; however, DISC1 genotype
was not taken into account in this cohort (27). Taken together,
we hypothesized that variation in the NDE1 gene may not
directly impact upon the risk for SZ but that its interaction
with DISC1 may be critical to this relationship.
To date, there have been no studies examining the effect of
NDEL1 genetic variation on SZ susceptibility. Moreover, most
likely because of limitations in sample sizes, there has been a
paucity of data on the relationship between NDEL1, NDE1 and
DISC1 genotype and risk for SZ. Therefore, we conducted a
case–control study in 275 Caucasian patients with SZ and
200 Caucasian healthy controls to assess the relationship
between NDEL1 and SZ and to test for an epistatic interaction
between NDEL1 genotype and DISC1 genotype on risk for SZ.
We speciﬁcally focused on the DISC1 functional variant,
Ser704Cys, as several lines of evidence converge to suggest
that this locus may be of particular importance in increasing
risk for SZ and in modifying the DISC1 protein interaction
with NDEL1 (Table 1), including: (i) the Ser 704 allele at
this single-nucleotide polymorphism (SNP) has previously
Table 1. Molecular context of Ser704Cys variation of DISC1
Genotype Clinical phenotypes References
Ser The NDEL1 rs1391768 SNP on risk for SZ
(Ser704/Ser704)
Current
study
Increased lifetime severity of delusions in SZ
(Ser704/Ser704)
(9)
Poor cognitive performance in control as well as
SZ (Ser704/Ser704)
(5)
Cys The NDE1 rs3784859 SNP on risk for SZ Current
study
Stronger cognitive decline in aged women
(Cys704/Cys704)
(7)
Molecular/anatomical phenotypes
Ser Reduction of HC GM volume in control and lower
HF NAA (Ser704/Ser704)
(5)
Altered engagement of HC during cognitive tasks
(Ser704/Ser704)
(5)
Lower expression of FEZ1, LIS1 and NDEL1 in
HC, andFEZ1inDLPFCof SZ(Ser704/Ser704)
(23)
Less interaction of DISC1with NDEL1 (24)
Predicted phosphorylation by DNA-PK
a
(NetPhosK 1.0)
Current
study
Cys Reduction of CC GM volume and decreased
fractional anisotropy in prefrontal WM
(3)
Less phosphorylation of ERK1/2 (3)
Less interaction of DISC1 with NDE1 Current
study
HF, hippocampal formation; NAA, N-acetylaspartate; DLPFC,
dorsolateral prefrontal cortex; CC, cingulate cortex; GM, gray matter;
WM, white matter; DNA-PK, DNA-dependent protein kinase.
aPossible phosphorylation of Ser704 is predicted by NetPhosK 1.0 server
(http://www.cbs.dtu.dk/services/NetPhosK/).
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been associated in our sample with increased lifetime severity
of delusions in patients with SZ (9); (iii) Ser704Cys has been
shown to impact hippocampal structure and function in
healthy controls (5); (iv) its location on DISC1 is proximal
to the region that is known to interact with NDEL1 (28,29);
(v) Ser704Cys has been shown to impact NDEL1 expression
in patients with SZ (23) and (vi) the Ser704Cys locus directly
impacts DISC1–NDEL1 protein binding (24). For epistatic
analyses with DISC1, we utilized an NDEL1-tagged SNP
that captured the majority of variance in the deﬁned linkage
disequilibrium (LD) structure of our sample. Finally, although
not a primary focus of this study, we also tested for an effect of
NDE1 genotype and its potential interaction with DISC1 on
risk for SZ in a subset of the sample for which this information
was available.
The second stage of the current study was directed at
extending the recently published ﬁnding of a gene–gene inter-
action between DISC1 and NDE1 (26). Although homologous
at the gene level, the relationship between the NDEL1 and
NDE1 proteins and their potential interactions with DISC1
has not yet been elucidated. To address the functional relation-
ship among DISC1, NDEL1 and NDE1, we ﬁrst examined
whether NDE1 and NDEL1 share a common binding
domain on DISC1. We then tested for an effect of DISC1
Ser704Cys on the NDE1–DISC1 protein interaction. Finally,
we bring these data together with our previously published
data (24) to compare the relative binding afﬁnity of the
DISC1 Cys704 versus Ser704 proteins to both NDEL1 and
NDE1 and we propose a potential competitive binding mech-
anism for NDE1 and NDEL1 in relation to DISC1 Ser704Cys.
RESULTS
Stage one
NDEL1. In a cohort of 275 Caucasian patients with SZ and
200 Caucasian healthy controls, four SNPs formed two
major yin–yang haplotypes, AGTC (57% frequency in SZ;
64% frequency in HCs) and GCCT (42% frequency in SZ;
36% frequency in HCs) as well as three additional haplotypes
that were very rare; each ,2.5% frequency. Because of the
very low frequency of the three ‘rare’ haplotypes, the subjects
were grouped by the status of only the two most common
haplotypes (AGTC, GCCT). Thus, NDEL1 diplotype analyses
focused on dichotomous groups comparing subjects who were
homozygous for the common haplotype (AGTC HZs) versus
subjects that carried at least one copy of the GCCT haplotype.
This resulted in a complete sample of 268 patients with SZ and
196 healthy controls, in which further association analyses
were conducted.
NDEL1 association with illness. x
2 analyses revealed that the
AGTC haplotype was more common in healthy controls than
in SZ patients, with a statistically signiﬁcant haplotypic
P-value of 0.041. In diplotype analyses, AGTC homozygosity
was signiﬁcantly more frequent in healthy controls (43%)
versus SZ patients (34%) (x
2 ¼ 3.90; P ¼ 0.048; OR ¼ 1.32;
95% CI 1.01–1.73).
As noted in Figure 1, the LD among the four SNPs compris-
ing the haplotypes was very high (r
2   0.93). All SNPs were
in HWE (data not shown) and, as expected on the basis of
the high LD between the SNPs in the haplotype block,
trend-level associations were found for each of the individual
SNPs with disease (all P-values , 0.06). Using the same
methodology as was used in the diplotype analysis (domi-
nant/recessive model of common allele homozygosity versus
risk allele carriers), each individual SNP was signiﬁcantly
associated with disease (all P-values , 0.05). The SNP that
best tagged the AGTC haplotype was SNP rs1391768, with
the G allele being over-represented in patients with SZ
(42.1% frequency) versus healthy controls (35.8% frequency)
(allelic x
2 ¼ 3.67; P ¼ 0.056; OR ¼ 1.33, 95% CI 0.99–
1.70). At SNP rs1391768, carriers of the G allele were at sig-
niﬁcantly greater risk for SZ than were subjects who were
homozygous for the A allele (x
2 ¼ 4.01; P ¼ 0.045; OR ¼
1.47, 95% CI 1.01–2.15). Thus, to avoid redundancy in ana-
lyses and on the basis of very strong LD between markers,
we utilized rs1391768 for all subsequent analyses.
Interaction between NDEL1 rs1391768 and DISC1
Ser704Cys. We tested for an epistatic interaction between
the NDEL1 rs1391768 genotype and the DISC1 Ser704Cys
polymorphism on risk for SZ ﬁrst by unconditional logistic
regression and second by conditioning the sample on DISC1
Ser704Cys. Owing to the low frequency of the Cys allele,
DISC1 Ser704Cys genotypes were grouped to compare sub-
jects carrying at least one copy of the Cys allele (Cys)
with subjects homozygous for the Ser allele (SerSer). For
NDEL1 SNP rs1391768, a dominant/recessive model of
Figure 1. LD structure of NDEL1 haplotype block. LD (D0) structure using
Haploview 3.32 (46). One SNP, rs 2012190, demonstrated extremely rare
(,05%) minor allele frequency and was excluded from further analyses. Of
the remaining SNPs, four formed a tight haplotype block spanning 36 kb,
encompassing the NDEL1 gene.
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utilized as this was the strongest model for disease risk.
Covariates included in the regression model were age, sex
and estimated IQ.
We used the likelihood ratio test in a backward stepwise
regression to test for interaction. All terms were retained in
the ﬁnal best ﬁt model. As predicted, the NDEL1   DISC1
interaction term was signiﬁcant (P ¼ 0.024) after accounting
for the main effects of NDEL1 rs1391768 (P ¼ 0.008);
DISC1 Ser704Cys (P ¼ 0.047); age (P ¼ 0.004); sex (P ,
0.001) and estimated IQ (P , 0.001). The ﬁnal model classi-
ﬁed subject type with 73.7% accuracy with a x
2 ¼ 111.98
(P , 0.001). To explicate the interaction effect, separate x
2
analyses for effects of NDEL1 on SZ risk were conducted,
dependent upon DISC1 Ser704Cys status. These analyses
revealed that the effect of the NDEL1 rs1391768 genotype
on risk for SZ was signiﬁcant in the context of a DISC1
SerSer background (x
2 ¼ 8.86; df ¼ 1; P ¼ 0.003; OR ¼
2.44; 95% CI 1.35–4.41) but was not signiﬁcant in patients
carrying one or two copies of the Cys allele (x
2 ¼ 0.01;
df ¼ 1; P ¼ 0.907; OR ¼ 1.03; 95% CI 0.61–1.73; Fig. 2).
NDE1. In a cohort of 267 Caucasian patients with SZ and 244
Caucasian healthy controls, overlapping with the sample gen-
otyped for NDEL1, a total of six SNPs in the NDE1 gene were
genotyped using methods described in what follows and in
more detail elsewhere (30). Four SNPs formed a single haplo-
type block (Table 2; Fig. 3). Haploview analyses revealed that
four haplotypes comprised this block, none of which was sig-
niﬁcantly associated with susceptibility to SZ; likewise, none
of the single markers was signiﬁcantly associated with
disease (Table 2). As no signiﬁcant associations was found
with NDE1 and since we were primarily interested in the
relationship between NDE1 and DISC1, we carried out
exploratory interaction analyses with each individual NDE1
SNP and DISC1 Ser704Cys, as described earlier, using separ-
ate x
2 analyses for effects of NDE1 on SZ risk, dependent
upon DISC1 Ser704Cys status. We did not utilize a regression
model for NDE1–DISC1 analyses, as NDE1 genotype did not
have a signiﬁcant main effect in initial tests. In the subset of
subjects for whom both NDE1 and DISC1 genotype were
available (170 cases and 125 controls), x
2 analyses revealed
that genotype at NDE1 rs3784859 had a signiﬁcant effect on
risk for SZ only in the context of a DISC1 Cys-carrying back-
ground (x
2 ¼ 3.89; df ¼ 1; P ¼ 0.049; OR ¼ 2.00; 95% CI
1.00–3.97), although this was not signiﬁcant in patients
with the SerSer genotype (x
2 ¼ 0.15; df ¼ 1; P ¼ 0.698;
OR ¼ 1.15; 95% CI 0.57–2.30; Fig. 4). Although these
results are quite modest and would not survive any level of
correction for multiple testing, it is of note that this is the
opposite pattern revealed in disease-associated risk relative
to the NDEL1 SNP, at which increased susceptibility was
present only in the context of a SerSer background. No
other NDE1 SNPs were signiﬁcant when conditioned on
DISC1 Ser704Cys (data not shown).
Stage two
Data from stage one provide evidence of epistasis between the
DISC1 and NDEL1 genes in SZ and weaker evidence of an
interaction between DISC1 and NDE1, consistent with the
previous report of genetic interaction between these genes in
a Finnish cohort (26). Thus, we hypothesized that these
three proteins (DISC1, NDEL1 and NDE1) may have func-
tional relationships to one another. To address this question,
we examined molecular interactions among these proteins
biochemically. DISC1–NDE1 and DISC1–NDEL1 inter-
actions as well as DISC1 and NDE1 self-associations have
already been reported (15,25,28–29). Thus, to expand upon
these previous data, we tested the potentials of NDEL1 self-
association and NDE1–NDEL1 heterodimerization by
co-immunoprecipitation. We observed speciﬁc NDE1–
NDEL1 interaction and NDEL1 self-association, although
their binding was signiﬁcantly weaker than the noted
DISC1–NDEL1 interaction (Fig. 5A). We conﬁrmed protein
interactions of NDE1–DISC1 and NDE1–NDEL1 at
endogenous protein levels by using anti-NDE1 and NDEL1
antibodies that do not cross-react with the other molecules
(Fig. 5C and D). Next, we explored the relationship between
DISC1–NDEL1 and DISC1–NDE1 binding. By using a
DISC1 deletion mutant that selectively lacks the NDEL1-
binding domain (amino acids 802–835) (24) in
co-immunoprecipitation, we observed that the same short
domain was required for DISC1–NDE1 protein interaction
(Fig. 5E and F). This result suggests that NDE1 and NDEL1
may compete with each other for DISC1. Feng et al. (15)
studied expression of NDE1 at the messenger RNA level: its
expression is the highest at embryonic day 11 (E11) and is
still detectable in the ventricular zone, intermediate zone and
cortical plate after E15.5. Expression level of NDEL1 is
reportedly increased, according to brain development, and is
prominent in the intermediate zone and cortical plate
(18,31). Thus, we conﬁrmed expression of NDE1 and
NDEL1 at the protein level in the cerebral cortex from neuro-
developmental stages to adulthood (Fig. 5G). Consistent with
the previous reports (15,18,31), we observed constant
expression of NDE1 at low level, in contrast to time-course
increase of NDEL1 during neurodevelopment. We observed
Figure 2. Effect of NDEL1 rs1391768 genotype in a DISC1 Ser704Cys back-
ground. Subjects are grouped by genotype at both NDEL1 rs1391768 and
DISC1 Ser704Cys. The X-axis represents NDEL1 genotype group. The
Y-axis represents OR. These data depict the DISC1–NDEL1 genotype inter-
action graphically. Sample sizes for each group are as follows: NDEL1 G
carrier   DISC1 Ser704Ser (SZ ¼ 74, HC ¼ 43); NDEL1 AA   DISC1
Ser704Ser (SZ ¼ 31, HC ¼ 44); NDEL1 G carrier   DISC1 Cys carrier
(SZ ¼ 52, HC ¼ 42) and NDEL1 AA   DISC1 Cys carrier (SZ ¼ 83,
HC ¼ 65).
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reﬂect possible post-translational modiﬁcation(s) on NDEL1.
Taken together, although it is probable that NDE1 and
NDEL1 interact with DISC1 in independent contexts, we
propose an alternative notion that both NDE1 and NDEL1
can simultaneously associate with DISC1 at certain but key
developmental time points.
To examine the interaction of NDE1 to DISC1 in cell cul-
tures, green ﬂuorescent protein (GFP)-tagged NDE1 was
exogenously expressed together with mock or HA-tagged
DISC1 in COS7 cells. GFP-NDE1 becomes co-localized
with DISC1 in punctuated patterns after expression of exogen-
ous DISC1 (Fig. 6A), similar to the observation of DISC1 and
NDEL1 (32). We previously reported that DISC1 is required
for the maintenance at the centrosome of the dynein motor
complex in which both NDE1 and NDEL1 are involved. We
also observed that DISC1 increases the accumulation of
NDEL1 to the centrosome (25). To address a competitive
relationship of NDE1 and NDEL1 for DISC1, we tested
whether overexpression of NDE1 affects the centrosomal
accumulation of endogenous NDEL1 in PC12 cells.
Expression of NDE1, but not an unrelated protein
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), led to
decreased accumulation of NDEL1 at the centrosome
(Fig. 6B). These data also suggest that NDEL1 and NDE1
may have a competitive role at the centrosome, probably in
association with DISC1. Our previous report indicated that
DISC1 is, at least in part, required for proper maintenance
of ERK1/2 activity in cultured neurons (3). Thus, we tested
Figure 3. LD structure of NDE1 haplotype block. LD (D0) structure using
Haploview 3.32 (24). Four of the six SNPs formed a tight haplotype block
spanning 30 kb, within the NDE1 gene.
Figure 4. Effect of NDE1 rs3784859 genotype in a DISC1 Ser704Cys back-
ground. Subjects are grouped by genotype at both NDE1 rs3784859 and
DISC1 Ser704Cys. The X-axis represents NDE1 genotype group. The Y-axis
represents OR. These data depict the DISC1–NDE1 genotype interaction
graphically. Sample sizes for each group are as follows: NDE1 G carrier  
DISC1 Ser704Ser (SZ ¼ 45, HC ¼ 35); NDE1 AA   DISC1 Ser704Ser
(SZ ¼ 28, HC ¼ 25); NDE1 G carrier   DISC1 Cys carrier (SZ ¼ 75, HC ¼
41) and NDE1 AA   DISC1 Cys carrier (SZ ¼ 22, HC ¼ 24).
Table 2. NDE1 haplotype and SNP association with SZ
Position (B35) Frequency (total) Frequency (cases) Frequency (controls) x
2-value P-value
Haplotype
GGAC 0.55 0.54 0.56 0.46 0.50
TCGC 0.29 0.29 0.28 0.13 0.72
GGGC 0.11 0.11 0.11 ,0.01 0.95
GGGT 0.04 0.05 0.03 2.32 0.13
SNP (allele)
rs8061376 (T)
a 15661969 0.30 0.29 0.16 0.69
rs4781679 (C)
a 15668934 0.29 0.28 0.13 0.72
rs3784859 (G)
a 15672904 0.45 0.43 0.56 0.45
rs12934645 (T)
a 15687868 0.05 0.03 2.77 0.10
rs8044738 (A) 15688555 0.30 0.29 0.19 0.67
Rs881803 (G) 15709835 0.31 0.28 0.76 0.38
aSNP included in the haplotype.
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actions are affected by ERK1/2. U0126 is known to block
NGF-induced activation of ERK1/2 in PC12 cells (33).
Protein interactions of NDE1–DISC1 or NDEL1–DISC1
were not altered by the addition of an ERK1/2 inhibitor
U0126, suggesting that ERK1 signaling may be independent
of these two protein interactions (Fig. 6C). Finally, we
tested whether the SZ-associated genetic variation at DISC1
Ser704Cys may affect DISC1–NDEL1 and DISC1–NDE1
protein interactions. We followed up on our previous report
that NDEL1 binds to DISC1-Cys704 more strongly than
DISC1-Ser704 (24) by carrying out a series of parallel
binding experiments with NDE1. Interestingly, we observed
the opposite binding pattern for NDE1 and NDEL1
with regard to DISC1 Ser704Cys, with a stronger afﬁnity
of NDE1 to DISC1-Ser704 than to DISC1-Cys704 (Fig. 6D
and E).
DISCUSSION
We report a signiﬁcant, although modest, association between
a four-locus NDEL1 haplotype (AGTC) and SZ. Subjects car-
rying one or more copies of the second most common haplo-
type (GCCT) were at increased risk for developing SZ.
Because of very high LD among the SNPs tested, analyses
of the best tagged SNP (NDEL1 rs1391768) captured most
of the effect noted in haplotype analyses. In addition, we
provide preliminary evidence of an epistatic interaction
between the functional DISC1 polymorphism, Ser704Cys
and variation in NDEL1, on SZ susceptibility. Subjects carry-
ing the G allele at NDEL1 rs1391768 demonstrated a more
than two-fold increased risk of developing SZ in the context
of DISC1 Ser704 homozygosity; however, in the background
of DISC1 Cys704, no increased risk was evident. These inter-
action data are both biologically plausible and consistent with
previous data, as the Ser704 allele at this polymorphism is
associated with increased severity of positive symptoms in
our cohort (9), has been identiﬁed as a risk allele for SZ (5)
and is associated with reduced NDEL1 expression in the HC
of SZ patients (23).
We further report no direct association between NDEL1’s
homolog, NDE1, and risk for SZ; however, our analyses did
reveal initial evidence for an interaction between NDE1 and
DISC1 on SZ susceptibility, although this was a much
weaker relationship than that noted between NDEL1 and
DISC1 and not statistically indicative of epistasis. Of note,
the pattern of risk associated with NDE1 genotype relative
to DISC1 Ser704Cys was the opposite of that seen with
NDEL1 genotype; speciﬁcally, an increased risk due to
NDE1 variation was present only in DISC1 Cys carriers and
not in DISC1 Ser homozygotes.
Both NDEL1 and NDE1 are essential components of the
dynein motor at the centrosome which is required for
normal neurodevelopmental processes, including neuronal
migration in the cerebral cortex and adult hippocampal
neurogenesis (12,34,35). DISC1 also has a parallel role in
the dynein complex, playing a key regulatory role in neuro-
developmental processes implicated in the pathophysiology
of SZ (24,25,29,35–38). In addition, NDEL1 is labeled by
its enzyme activity in vitro as an endo-oligopeptidase (39)
and may be a protein of particular interest as a potential
treatment target for novel antipsychotic medications which
act as neurotensin agonists (40,41). Interaction of DISC1
and NDEL1 may be important, at least as evidenced by its
crucial role in neurite outgrowth of differentiating PC12
cells (24).
Our results are consistent with both expression data, in
which the DISC1 Ser704 allele predicted reduced NDEL1
expression in SZ patients (23), and protein-binding data,
which suggest that the Ser704 protein binds less readily to
NDEL1 than does the Cys704 protein (24). Our interaction
data of DISC1, NDEL1 and NDE1 are compatible with a
recent report of signiﬁcant linkage between SZ and the
chromosomal region containing the NDEL1 homolog, NDE1,
in a subset of families conditioned on the presence of a
DISC1 risk haplotype (26). As the relationship between the
protein products of these homologous genes (NDEL1 and
NDE1) has not yet been elucidated, these ﬁndings form an
important link to our results from the second stage of the
current study.
Speciﬁcally, we have now demonstrated an epistatic inter-
action between DISC1 and NDEL1 at the gene level, which
follows logically from the previous biological evidence sup-
porting an interaction at the protein level. Likewise, Hennah
et al. (26) provided evidence of gene–gene interaction
between DISC1 and NDE1, supported by our association
results, and in our stage two analyses we provide initial data
describing a biological association between NDE1 and
DISC1, with an opposite pattern of binding as that reported
by our group for NDEL1 (24). These data may indicate that
both NDEL1 and NDE1 are independently implicated in the
pathophysiology of SZ, or rather, this may suggest that imbal-
anced interaction of NDEL1 and NDE1 with DISC1 disturbs
coordinated functions of the DISC1-associated protein
complex. Although additional studies will be required to
fully understand the implications of our hypothesized competi-
tive binding model of NDEL1 and NDE1 with regard to
DISC1 Ser704Cys, disturbance of this pattern may disrupt
normal neurodevelopment. Speciﬁcally, expression proﬁles
of NDEL1 versus NDE1 differ during the developmental
period marked by neuronal maturation, with NDEL1 more
prominently expressed. Although speculative, a perturbation
of this balance may result in abnormal binding of these pro-
teins to DISC1 and interfere with normal neuron growth, offer-
ing a possible explanation for the observation in brain imaging
that the DISC1 Ser704 allele is associated with reduced gray
matter in the HC (5).
In summary, we present preliminary evidence indicating an
epistatic interaction between NDEL1 and DISC1, as the effect
of NDEL1 on risk for SZ appears to be reliant on a background
of DISC1 Ser704Ser genotype. Further, we report new evi-
dence in support of a shared binding domain for NDEL1
and NDE1 to DISC1, with opposite effects of the DISC1
Ser704Cys mutation on binding patterns. Finally, we hypoth-
esize a potential competitive binding mechanism to explain
these results. These data support the importance of assessing
the interactions between putative risk genes and proteins
located within known molecular networks implicated in the
pathophysiology of SZ.
Human Molecular Genetics, 2008, Vol. 17, No. 16 24672468 Human Molecular Genetics, 2008, Vol. 17, No. 16MATERIALS AND METHODS
Stage one
Subjects: NDEL1–DISC1 association. The study group
included 275 Caucasian patients with SZ or schizoaffective
disorder (30.9% female) with a mean age of 45.0+10.5
years, mean education of 13.0+2.2 years and an estimated
IQ (based on WRAT-3 Reading) of 96.1+11.8. All subjects
provided written informed consent to an Institutional Review
Board of the North Shore–Long Island Jewish Health
System (NSLIJHS)-approved protocol. Patients were recruited
from the inpatient units of the Zucker Hillside Hospital
(ZHH), a division of the NSLIJHS, in Glen Oaks, NY, USA.
All patients were clinically stable at the time of assessment.
Clinical characteristics that were collected included duration
of illness 17.7+10.6 years, age of onset (ﬁrst medicated)
21.4+6.3 years and global assessment of function 38.1+
15.2.
Caucasian healthy control subjects (n ¼ 200) were recruited
from the general population via word of mouth, newspaper
and internet advertisements and posted ﬂyers. Subjects were
excluded if they had an Axis I diagnosis, active or recent
substance abuse or if they had a ﬁrst-degree relative with a
known or suspected Axis I disorder, based on family history
questionnaire. Controls were 62.0% female, had a mean age
of 47.7+15.7 years, mean education of 15.8+2.4 years
and an estimated IQ (based on WRAT-3 Reading) of
105.6+9.2.
All subjects were Caucasian by self-report and drawn from
a single geographic location (Glen Oaks, NY area, USA).
Although population stratiﬁcation is a potential confound in
any case–control study, we have recently demonstrated that
undetected substructure is not present in our geographically
homogeneous population. In our recent whole-genome associ-
ation study (30) of a case–control cohort collected by the
same methods described earlier, we tested for stratiﬁcation
using 210 ancestry informative markers selected for
maximal informativeness and observed no differences
between patients and controls beyond chance levels. More-
over, in the same cohort, none of the subjects deviated from
a single population as assessed by the STRUCTURE
program (42).
Diagnostic measures. Patient diagnosis was established
through structured interview (Structured Clinical Interview—
DSM-IV; SCID-IV) (43) and conﬁrmed by diagnostic consen-
sus conference, which utilizes expert clinical opinion along-
side SCID-IV data and corroborating medical record
information. Healthy controls for the project were assessed
using the Structured Clinical Interview for DSM-IV, Non-
Patient Edition (43), speciﬁcally designed for healthy subjects
to rule out Axis I diagnoses. In addition to the structured diag-
nostic interview, potential subjects are screened to rule out any
history of CNS trauma, neurological disorder or previously
diagnosed learning disability.
DNA procedures. Genomic DNA was extracted from venous
blood samples, and six SNPs (rs12601035, rs1391768,
rs1391766, rs931672, rs2012190 and rs35261231) were geno-
typed by 50 exonuclease assay, using the primer-probe sets
available as Taqman
w Assays-on-Demand (Applied Biosys-
tems, Foster City, CA, USA). SNPs were selected, based on
available Taqman inventories at the time of genotyping, to
span the entirety of NDEL1, including 50 and 30 ﬂanking
regions. Call rates exceeded 99% across the six SNPs. Allele
frequencies, Hardy–Weinberg equilibrium (HWE) and LD
structure were examined using Haploview 3.32 (44). One
SNP, rs2012190, demonstrated extremely rare (,0.5%) minor
allele frequency and was excluded from further analyses. Of
the remaining SNPs, four formed a tight haplotype block span-
ning 36 kb and encompassing the gene, as shown in Figure 1.
One SNP (rs12601035), located 8k bu p s t r e a m o f NDEL1,
was not part of the NDEL1 haplotype block and was also
excluded from further analyses. For the four SNPs in the
NDEL1 haplotype block, phase and diplotype assignment
were estimated using PHASE 2.1.1 (45). Genotyping for
DISC1 Ser704Cys was conducted as described previously (4).
NDEL1 association with illness. None of the four SNPs in the
haplotype deviated from HWE (P-values . 0.05). As
Figure 5. Protein interaction of DISC1, NDEL1 and NDE1. (A) Self-association of NDEL1 and hetero-oligomerization of NDEL1 and NDE1. HA-tagged
DISC1, NDEL1 or GAPDH were transfected with myc-tagged NDEL1 or NDE1 in HEK293 cells. Immunoprecipitates with an anti-HA antibody were analyzed
by western blotting with an anti-myc antibody. Myc-tagged NDEL1 is co-precipitated with HA-tagged DISC1 and NDEL1, but not with GAPDH (top panel).
NDE1 is also co-precipitated with HA-tagged NDEL1, but not with GAPDH (top panel), suggesting that NDEL1 self-associates and forms a hetero-oligomer
with NDE1. For a negative control in co-immunoprecipitation, we used a rabbit IgG and observed no precipitation of target proteins (second panel). The inputs of
each protein in co-immunoprecipitation are also shown (bottom panels). (B) The speciﬁcities of monoclonal antibodies against NDE1 (see Materials and
Methods section) and NDEL1 (24) were evaluated by western blotting. Anti-NDE1 antibody recognizes exogenous NDE1 protein but not exogenous
NDEL1 protein. On the other hand, anti-NDEL1 antibody detects exogenous NDEL1 protein but not exogenous NDE1 protein. (C) Endogenous protein inter-
action of NDE1–DISC1 was conﬁrmed by co-immunoprecipitation with the tissue extract of rat adult cerebral cortex. A monoclonal antibody against NDE1 was
used for immunoprecipitation. (D) Endogenous protein interaction of NDE1–NDEL1 was conﬁrmed by co-immunoprecipitation with the cell extract of undif-
ferentiated PC12 cells. A monoclonal antibody against NDEL1 was used for immunoprecipitation. (E) Amino acids 802–835 of DISC1 are critical for DISC1–
NDEL1 interaction. HEK293 cells were transfected with myc-tagged NDEL1 and HA-tagged DISC1 or DISC1 lacking amino acids 802–835 [DISC1D(802–
835)]. Lysates were then immunoprecipitated with an anti-myc antibody and analyzed by western blotting with an anti-HA antibody. Deletion of amino acids
802–835 of DISC1, which is a critical domain for DISC1–NDEL1 interaction we previously reported, completely abolished the interaction of exogenous DISC1
[DISC1D(802–835)] with NDEL1 (top panel). The inputs of each protein are shown (bottom panels). (F) Amino acids 802–835 of DISC1 are critical for
DISC1–NDE1 interaction. Myc-tagged NDE1 was transfected with HA-tagged DISC1 or HA-tagged DISC1D(802–835) in HEK293 cells. Protein extracts
were immunoprecipitated with an anti-myc antibody. Deletion of amino acids 802–835 of DISC1 dramatically weakened the interaction with NDEL1 in
co-immunoprecipitation (top panel). The inputs are shown (bottom panels). (G) Protein expression of NDE1 and NDEL1 in the cerebral cortex. NDE1
protein was expressed constantly at a low level from E14 to adulthood. Expression of NDEL1 is increased according to brain development, with the highest
expression at P7.
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yang haplotype. Since analyses were designed to examine
DISC1 status at the level of the individual subject, and to
maximize cell size for these comparisons, phased diplotype
and individual genotype associations were examined under a
dominant/recessive model, using df ¼ 1 x
2 test statistics, com-
paring homozygotes of the most common variant versus car-
riers of risk variant. Odds ratios (ORs) were calculated as a
measure of effect size for all association analyses.
NDEL1 and DISC1 epistasis. We tested for a genotype inter-
action between the best tagged SNP for the most common
NDEL1 haplotype (rs1391768) and DISC1 Ser704Cys by uti-
lizing a likelihood ratio test in an unconditional logistic
regression model, with subject type (SZ versus healthy con-
trols) as the dependent measure and entering NDEL1
rs1391768 genotype, DISC1 Ser704Cys genotype and the
interaction term NDEL1   DISC1 in a backward stepwise
model. In addition, x
2 analyses were conducted to determine
ORs for the signiﬁcant interaction, by conditioning the
sample on DISC1 Ser704Cys.
It should be noted that the secondary analyses with the
NDE1 gene utilized a patient sample directly overlapping
the sample used in the primary analyses (n ¼ 267) and a
slightly larger healthy control sample (n ¼ 244) recruited
and diagnosed by the same methods described earlier. These
samples were comparable with the NDEL1–DISC1 sample
in both demographics and illness features but were genotyped
by different methods. Brieﬂy, genomic DNA was extracted
from whole blood and hybridized to two chips containing
262 000 and 238 000 SNPs on the basis of the manufac-
turer’s (Affymetrix, Santa Clara, CA, USA) speciﬁcations.
Patients and controls were proportionally distributed on each
96-well plate. Genotype calls were made using Bayesian
robust linear model with Mahalanobis distance classiﬁer
algorithm threshold at 0.5 applied to batches of 100 samples.
Mean call rates ,90% on both chips (or ,85% on one
chip) were rejected, resulting in a mean call rate for the
retained sample of 97%. For additional detail on genotyping
methodology, see the work of Lencz et al. (30). Statistical pro-
cedures to test for association between NDE1 and SZ and
interactions between NDE1 and DISC1 were carried out iden-
tically to those described earlier for NDEL–DISC1 analyses.
Stage two
Plasmids and antibodies. The deletion DISC1 expression con-
struct was made by PCR-based mutagenesis protocol (24). The
following antibodies were also used: mouse monoclonal
antibody against g-tubulin (Sigma-Aldrich, St Louis, MO,
USA); mouse monoclonal antibodies against HA-tag and
myc-tag (BAbCO, Berkeley, CA, USA); rabbit polyclonal
antibody against HA-tag (Clontech, Mountain View, CA,
USA); rabbit polyclonal antibody against myc-tag (Santa
Cruz, Santa Cruz, CA, USA). Rabbit polyclonal anti-GAPDH
antibody was prepared as described previously (46). Rabbit
polyclonal anti-DISC1 antibody (D27) was a gift from
Dr Nicholas J. Brandon. Rat monoclonal antibody against
NDEL1 was characterized in the previous report (24). Rat
monoclonal antibody against NDE1 was newly prepared for
this study, according to the established protocol (47).
Cell culture and transfection. HEK293 and COS7 cells were
maintained in Dulbecco’s modiﬁed Eagle medium (DMEM)
with 10% fetal bovine serum (FBS) and 1% penicillin–
streptomycin (PS). PC12 cells were maintained in DMEM
with 10% FBS, 5% horse serum (HS) and 1% PS. Transfection
of expression constructs was carried out with Lipofectamine
2000 (Invitrogen, Carlsbad, CA, USA) for PC12 cells, with
PolyFect Transfection Reagent (Qiagen, Valencia, CA,
USA) for HEK293 cells, and FuGENE6 (Roche Applied
Science, Indianapolis, IN, USA) for COS7 cells.
Co-immunoprecipitation and cell extraction. Immunoprecipi-
tation: Cells were lysed in a RIPA buffer (50 mM Tris–HCl,
pH 7.4, 150 mM NaCl, 5 mM MgCl2,5 m M dithiothreitol,
1m M phenylmethylsulfonyl ﬂuoride, 1 mM ethylenediaminete-
traacetic acid, 1% Triton X-100 and protease inhibitor
mixture) (Roche, Basel, Switzerland). Rat adult cerebral cor-
texes were homogenated in the RIPA buffer. Supernatant frac-
tions obtained after centrifugation at 14 000g for 10 min were
incubated with primary antibodies (rabbit polyclonal antibody
against HA-tag or against myc-tag; rat monoclonal antibody
against NDE1 or against NDEL1) overnight, followed by the
addition of Protein G Plus/Protein A agarose (Calbiochem,
Darmstadt, Germany) for 1 h. The immunoprecipitates were
analyzed with SDS–PAGE followed by western blotting
after extensive washing.
Figure 6. Possible competition of NDE1 and NDEL1 for DISC1. (A) Change in subcellular distribution of NDE1 by overexpression of DISC1. Exogenous
expression of DISC1 (DISC1-Ser704) (red) leads to punctuated distribution of GFP-tagged NDE1 (green) in COS7 cells. Scale bar, 10 mm. (B) NDE1
affects the accumulation of NDEL1 to the centrosome in PC12 cells. Endogenous NDEL1 (red) is localized in the perinuclear region, including the centrosome,
in undifferentiated PC12 cells. Overexpression of NDE1 (green, upper panels), but not GAPDH (green, lower panels), redistributes endogenous NDEL1 (red)
from the perinuclear regions (lower panels). To semi-quantify the localization change, immunointensity of NDEL1 in the centrosome area (white circle) relative
to that in the whole cell region surrounded by green line was examined. Bars represent averages of each group of cells in blinded experiments ( P , 0.005). Error
bars represent SEM. Representative images are shown. Blue, nucleus; red, NDEL1; green, NDE1 or GAPDH; white, g-tubulin (indicated by arrowheads). Scale
bar, 10 mm. (C) Protein interactions of DISC1–NDE1 and DISC1–NDEL1 were not affected in the presence of U0126, which is known to block NGF-induced
activation of ERK1/2 in PC12 cells. Error bars represent SEM. (D) HEK 293 cells were transfected with HA-tagged DISC1
Ser or DISC1
Cys together with myc-
tagged NDE1. Lysates were then immunoprecipitated with an anti-myc antibody and western-blotted with an antibody to HA to analyze the DISC1–NDE1
interaction. Interaction of DISC1
Ser with NDE1 is slightly stronger than that with DISC1
Cys as shown in co-immunoprecipitation with an anti-myc antibody
(top panel). The inputs are also shown (bottom panels). (E) Inﬂuence of the Ser704Cys variation of DISC1 on the DISC1–NDEL1 and DISC1–NDE1
protein interactions. NDE1 binds to DISC1
Ser more tightly than to DISC1
Cys (left graph and D), whereas NDEL1 interacts with DISC1
Ser less tightly than
with DISC1
Cys as published previously (middle graph). The opposite binding pattern for NDE1 and NDEL1 with regard to DISC1 Ser704Cys results in
about 1.6-fold difference between DISC1
Ser and DISC1
Cys (right graph) (P ¼ 0.054). Error bars represent SEM.
Human Molecular Genetics, 2008, Vol. 17, No. 16 2471Immunoﬂuorescent staining. Cells were ﬁxed with ice-cold
methanol at –208C 1 day after transfection. After blocking
with 1.5% bovine serum albumin and 0.5% normal goat
serum in PBS, cells were treated with primary antibodies for
1 h followed by the reaction with secondary antibodies
conjugated to Rhodamine Red-X, Cy2 and Cy5 (Jackson
ImmunoResearch, West Grove, PA, USA) for 1 h. Hoechst
33258 (Molecular Probes) was used at 1:500 dilution for
3 min to visualize nuclei. Confocal microscopy (Zeiss LSM
510 Meta, Grottingem, Germany) was used for epiﬂuorescent
image collection. To quantify the distribution of NDEL1 at the
centrosome in the cells, a circle with 3 mm diameter was
drawn centering on the g-tubulin and deﬁned as the area,
including the centrosome. In all experimental groups, the
immunointensity of NDEL1 in the whole cell area versus cen-
trosome area was quantiﬁed with Image J (http://rsb.info.nih.
gov/ij/). The intensity ratio of the signal of more than 30
cells per group was analyzed in three independent experiments
in a blinded manner. Statistical analyses were conducted by
using a one-way ANOVA followed by post hoc testing.
Values depicted are means+SEM.
Quantitative and statistical analyses. Quantitative densito-
metric measurement of western blotting was performed
using Image J. Statistical analyses were conducted by Stu-
dent’s t-test or Welch’s t-test. Values depicted are mean+
SEM.
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